⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Public Affairs and Patient Advocacy Leader Kim Isenberg Joins National Organization for Rare Disorders Board of Directors
prnewswire.com
SNY
TAK
Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting
prnewswire.com
SNY
Europe $7.4 Bn Insulin Pen Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2025-2034
globenewswire.com
LLY
MDT
NVO
SNY
BDX
North America $9.2 Bn Insulin Pen Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2025-2034
globenewswire.com
BDX
LLY
MDT
NVO
SNY
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos Health, McCann Health, Amgen, AXPIRA, Pfizer and More - ResearchAndMarkets.com
businesswire.com
SNY
AMGN
PFE
Orano Med Enters Next Phase of Collaboration with Roche
businesswire.com
SNY
Orano Med franchit une nouvelle étape dans sa collaboration avec Roche
businesswire.com
SNY
Press Release: Sanofi completes acquisition of Vicebio
globenewswire.com
SNY
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes
businesswire.com
SNY
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
prnewswire.com
NVO
ULTX
SGMO
PFE
BMN
SNY
CHGC
RHHBY
ALNY
BIIB
BAY
TSEM
CSL
HEMA
LFB
OCT
SOBI
ASC